{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:46:14Z","timestamp":1761965174960,"version":"3.37.3"},"reference-count":18,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.2337\/dci19-0077","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:25:08Z","timestamp":1582248308000},"page":"518-521","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":17,"title":["Rediscovery of the Second \u03b2-Cell Hormone: Co-replacement With Pramlintide and Insulin in Type 1 Diabetes"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-3036","authenticated-orcid":false,"given":"Matthew C.","family":"Riddle","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes & Clinical Nutrition, Department of Medicine, Oregon Health & Science University, Portland, OR"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"2022031300331894300_B1","first-page":"414","article-title":"Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone","volume":"127","author":"Westermark","year":"1987","journal-title":"Am J Pathol"},{"key":"2022031300331894300_B2","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031300331894300_B3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0306-9877(91)90150-W","article-title":"Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus","volume":"36","author":"Cooper","year":"1991","journal-title":"Med Hypotheses"},{"key":"2022031300331894300_B4","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"\u03b2-Cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am J Pathol"},{"key":"2022031300331894300_B5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/clinchem\/42.4.576","article-title":"Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma","volume":"42","author":"Percy","year":"1996","journal-title":"Clin Chem"},{"article-title":"Amylin: Physiology and Pharmacology. Vol. 52: Advances in Pharmacology","year":"2005","author":"Young","key":"2022031300331894300_B6"},{"key":"2022031300331894300_B7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(92)90785-2","article-title":"Amylin concentrations and glucose control","volume":"339","author":"Koda","year":"1992","journal-title":"Lancet"},{"key":"2022031300331894300_B8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/j.1552-4604.1996.tb04147.x","article-title":"Pharmacokinetics and pharmacodynamics of AC137 (25,28,29 tripro-amylin, human) after intravenous bolus and infusion doses in patients with insulin-dependent diabetes","volume":"36","author":"Colburn","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"2022031300331894300_B9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","article-title":"Effect of 14 days\u2019 subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM","volume":"39","author":"Kolterman","year":"1996","journal-title":"Diabetologia"},{"key":"2022031300331894300_B10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"2022031300331894300_B11","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1210\/jc.2015-3952","article-title":"Effect of pramlintide on postprandial glucose fluxes in type 1 diabetes","volume":"101","author":"Hinshaw","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300331894300_B12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jc.2017-02265","article-title":"Pramlintide but not liraglutide suppresses meal-stimulated glucagon responses in type 1 diabetes","volume":"103","author":"Galderisi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300331894300_B13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"2022031300331894300_B14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus: a 1-year, randomized controlled trial","volume":"21","author":"Ratner","year":"2004","journal-title":"Diabet Med"},{"key":"2022031300331894300_B15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2337\/dc16-0089","article-title":"Mitigating meal-related glycemic excursions in an insulin-sparing manner during closed-loop insulin delivery: the beneficial effects of adjunctive pramlintide and liraglutide","volume":"39","author":"Sherr","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031300331894300_B16","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.2337\/dc18-1091","article-title":"Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadminstration of pramlintide and regular human insulin: a randomized, two-way crossover study","volume":"41","author":"Riddle","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031300331894300_B17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/dc19-1922","article-title":"A novel dual-hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized controlled crossover trial","volume":"43","author":"Haider","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031300331894300_B18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/dom.12504","article-title":"Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes","volume":"17","author":"Riddle","year":"2015","journal-title":"Diab Obes Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/3\/518\/530774\/dci190077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/3\/518\/530774\/dci190077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:50:54Z","timestamp":1647143454000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/3\/518\/35673\/Rediscovery-of-the-Second-Cell-Hormone-Co"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,11]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0077","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2020,2,11]]}}}